Paper8405033
Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014.
Kuhn JM and 6 others. Eur J Clin Pharmacol, 1993. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014. Papers, record 8405033. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8405033
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Growth Hormone | Major topic |
| Growth Hormone-Releasing Hormone | Major topic |
| Peptides, Cyclic | Major topic |
| Somatostatin | Major topic |
| Adult | |
| Humans | |
| Injections, Intravenous | |
| Injections, Subcutaneous | |
| Male |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2451917 | Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. | Biochem Biophys Res Commun | 1988 | https://conductscience.org/library/papers/2451917 | PubMed |
| 2 | 2858917 | Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. | Science | 1985 | https://conductscience.org/library/papers/2858917 | PubMed |
| 3 | 2055192 | Growth of human breast cancer cell lines is inhibited by the somatostatin analog BIM23014. | Endocrinology | 1991 | https://conductscience.org/library/papers/2055192 | PubMed |
| 4 | 2878079 | Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. | J Med Chem | 1986 | https://conductscience.org/library/papers/2878079 | PubMed |
| 5 | 6315757 | Growth hormone binding to cultured human breast cancer cells. | J Clin Endocrinol Metab | 1984 | https://conductscience.org/library/papers/6315757 | PubMed |
| 6 | 2886933 | Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis. | Neuroendocrinology | 1987 | https://conductscience.org/library/papers/2886933 | PubMed |
| 7 | 2839551 | Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. | J Clin Invest | 1988 | https://conductscience.org/library/papers/2839551 | PubMed |
| 8 | 3312244 | Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. | J Cell Biochem | 1987 | https://conductscience.org/library/papers/3312244 | PubMed |
| 9 | 2880660 | Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. | Cancer Res | 1987 | https://conductscience.org/library/papers/2880660 | PubMed |
| 10 | 2893361 | Mu-opiate binding and morphine antagonism by octapeptide analogs of somatostatin. | Peptides | 1987 | https://conductscience.org/library/papers/2893361 | PubMed |
| 11 | 2872570 | Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors. | Life Sci | 1986 | https://conductscience.org/library/papers/2872570 | PubMed |
| 12 | 2884564 | Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. | N Engl J Med | 1987 | https://conductscience.org/library/papers/2884564 | PubMed |
| 13 | 2569933 | Somatostatin and somatostatin analogues in oncology. | Cancer Treat Rev | 1989 | https://conductscience.org/library/papers/2569933 | PubMed |
| 14 | 8095269 | Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly. | J Clin Endocrinol Metab | 1993 | https://conductscience.org/library/papers/8095269 | PubMed |
| 15 | 2900205 | Effect of a long-acting somatostatin derivative SMS 201-995 (sandostatin) on glucose homeostasis in type I diabetes mellitus. | Horm Res | 1988 | https://conductscience.org/library/papers/2900205 | PubMed |
| 16 | 2885701 | Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin. | Life Sci | 1987 | https://conductscience.org/library/papers/2885701 | PubMed |
| 17 | 2869278 | Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin. | Lancet | 1986 | https://conductscience.org/library/papers/2869278 | PubMed |
| 18 | 6129852 | Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. | Biochem Biophys Res Commun | 1982 | https://conductscience.org/library/papers/6129852 | PubMed |
| 19 | 2869845 | Interaction between growth hormone releasing factor (GRF) and somatostatin analogue (SMS 201-995) in normal subjects. | Clin Endocrinol (Oxf) | 1985 | https://conductscience.org/library/papers/2869845 | PubMed |
| 20 | 2891721 | Differential effects of somatostatin (SRIH) and a SRIH analog, SMS 201-995, on the secretion of growth hormone and thyroid-stimulating hormone in man. | J Clin Endocrinol Metab | 1988 | https://conductscience.org/library/papers/2891721 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35128405 | Cyclic peptide drugs approved in the last two decades (2001-2021). | RSC Chem Biol | 2022 | https://conductscience.org/library/papers/35128405 | PubMed |
| 35000098 | Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers. | Pituitary | 2022 | https://conductscience.org/library/papers/35000098 | PubMed |
| 32557353 | Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies. | J Endocrinol Invest | 2020 | https://conductscience.org/library/papers/32557353 | PubMed |
| 32121432 | Somatostatin Analogs in Clinical Practice: a Review. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32121432 | PubMed |
| 31412614 | Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31412614 | PubMed |
| 16984213 | Pharmacokinetic profile of the somatostatin analogue lanreotide in individuals with chronic hepatic insufficiency. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16984213 | PubMed |
| 10435849 | Long-term treatment of acromegaly with the somatostatin analogue SR-lanreotide. | J Endocrinol Invest | 1999 | https://conductscience.org/library/papers/10435849 | PubMed |
| 7826822 | Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7826822 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2L11 | 10018 | PubTator's text mining | https://conductscience.org/library/genes/10018 | NCBI Gene |
| GGH | 8836 | PubTator's text mining | https://conductscience.org/library/genes/8836 | NCBI Gene |
| GH1 | 2688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
| GHRH | 2691 | PubTator's text mining | https://conductscience.org/library/genes/2691 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8405033
GET https://conductscience.org/api/papers/v1/8405033/references?page=2